BCU Wealth Advisors LLC Buys Shares of 7,572 CVS Health Co. (NYSE:CVS)

BCU Wealth Advisors LLC acquired a new stake in CVS Health Co. (NYSE:CVS) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 7,572 shares of the pharmacy operator’s stock, valued at approximately $598,000. CVS Health accounts for about 0.6% of BCU Wealth Advisors LLC’s portfolio, making the stock its 23rd biggest position.

Several other large investors have also added to or reduced their stakes in the business. Atticus Wealth Management LLC increased its position in shares of CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the last quarter. USA Financial Formulas raised its stake in CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares during the period. Cornerstone Planning Group LLC boosted its stake in shares of CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 243 shares during the period. ZRC Wealth Management LLC raised its stake in CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares during the period. Finally, Northwest Financial Advisors acquired a new stake in CVS Health during the 4th quarter valued at $42,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Leerink Partnrs lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Cantor Fitzgerald cut CVS Health from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $87.00 to $58.00 in a report on Wednesday, May 1st. Piper Sandler lifted their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. Finally, StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Nine research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $76.75.

Insider Activity at CVS Health

In other news, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The shares were bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.24% of the stock is currently owned by company insiders.

CVS Health Price Performance

Shares of CVS Health stock traded down $0.34 during trading on Thursday, reaching $57.10. 7,934,419 shares of the company’s stock were exchanged, compared to its average volume of 11,907,941. The firm’s 50-day moving average price is $67.98 and its 200 day moving average price is $72.13. The company has a market cap of $71.68 billion, a P/E ratio of 10.04, a PEG ratio of 0.55 and a beta of 0.56. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a 1-year low of $53.70 and a 1-year high of $83.25.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company posted $2.20 EPS. As a group, research analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.66%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s payout ratio is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.